Clinical Trial Update: Interferon Alfa and Interleukin-2 in Treating Patients With Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

Clinical trial update describing a phase 2 study of interferon alfa and interleukin-2 in patients with metastatic kidney cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• Interferon Alfa (interferon alfa)
• Interleukin-2 (interleukin-2)

Snippet

Sponsor: Blumenthal Cancer Center at Carolinas Medical Center | Conditions: Kidney Cancer | Phase 2 | Status: UNKNOWN